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0022-2836 © 2011 Elsevier Ltd. Open accToxin–antitoxin (TA) loci are common in archaea and prokaryotes and
allow cells to rapidly adapt to changing environmental conditions through
release of active regulators of metabolism. Many toxins are endonucleases
that target cellular mRNA and tRNAs, while the antitoxins tightly wrap
around the toxins to inhibit them under normal circumstances. The
antitoxins also bind to operators in the promoter regions of the cognate
TA operon and thereby regulate transcription. For enteric vapBC TA loci, the
VapC toxins specifically cleave tRNAfMet and thus down-regulate protein
synthesis. Here, we describe the crystal structure of the intact Shigella
flexneriVapBC TA complex, determined to 2.7 Å resolution. Both in solution
and in the crystal structure, four molecules of each protein combine to form
a large and globular hetero-octameric assembly with SpoVT/AbrB-type
DNA-binding domains at each end and a total molecular mass of about
100 kDa. The structure gives new insights into the inhibition of VapC toxins
by VapB and provides the molecular basis for understanding transcrip-
tional regulation through VapB dimerization.© 2011 Elsevier Ltd. Open access under CC BY license.Introduction
Toxin–antitoxin (TA) loci are widespread in pro-
karyotes and code for an active “toxin” molecule,
typically, a translational regulator, and an “antitox-
in” that forms a tight complex with the toxin and
thus inhibits it1-3. Upon changes in the surrounding
environment, such as during nutritional stress, theess: deb@mb.au.dk.
titoxin; PIN,
orphous replacement
lap endonuclease-1;
ethyl superimidate;
t assay.
ess under CC BY license.antitoxin is degraded and the toxin is released
intracellularly. Functions have not been ascribed to
all types of toxins, but many possess “RNA
interferase” activity, that is, they are able to cleave
mRNA or tRNA to regulate overall rates of
translation.4 At the genomic level, TA loci are
organized in a tightly controlled operon with the
toxin downstream of the antitoxin, transcriptionally
regulated through a DNA-binding domain on the
antitoxin.5 Type II TA loci, for which both toxin and
antitoxin are proteins, have been subdivided into six
evolutionarily independent families: ccdAB, mazEF,
phd/doc, parDE, higAB, and relBE.5 VapC, HigA, and
MazF toxins are active ribonucleases in isolation3,6,7
while the RelE-type toxins require the ribosome in
order to cleave mRNA during translation.8,9 CcdB
and ParE toxins, on the other hand, target DNA
Table 1. Crystallographic data statistics
Native U (SIRAS)
Data collection
Wavelength (Å) 0.94645 1.04002
Space group P6122 P6122
Cell dimensionsa
a, b, c (Å) 91.4, 91.4, 549.1 92.4, 92.4, 548.9
α, β, γ (°) 90, 90, 120 90, 90, 120
Resolution (Å) 39.6–2.7 39.5–2.9
I/σ(I)b 20.5 (2.2) 28.76 (8.79)
Completeness (%) 99.6 (96.9) 99.5 (95.6)
Redundancy 22.4 (21.0) 6.1 (5.5)
Mosaicity (°) 0.1 0.09
Rsym (%) 16.6 (164.8) 4.3 (19.2)
Rmrdg,F (%)
c 9.0 (70.7) 3.5 (18.1)
Refinementd
Resolution (Å) 39.6–2.7
No. of reflections 38,932
Rwork/Rfree (%) 18.2/23.7 (28.9/39.6)
Total protein atoms 6280
Total water molecules 205
B-factor (Å2) 65.9
RMSD bonds (Å) 0.0052
RMSD angles (°) 0.838
Ramachandran statisticsd (%)
Favored 95.6
Allowed 4.1
Outliers 0.3
Crystallographic data collection and refinement statistics for
VapBC native and uranium derivative crystals.
a Values given by XSCALE.
b Figures in parentheses represent the outermost-resolution
shell (2.76–2.69 Å).
c Redundancy-independent R-factor.
d Values given by PHENIX.
714 Structure of the S. flexneri VapBC Complexgyrase and thus inhibit DNA replication,10,11 while
Doc has been proposed to inhibit translation
through static binding to the ribosome in a way
akin to antibiotics and thus does not induce RNA
cleavage.12
In the largest TA family, vapBC, the VapC toxin
contains a PilT N-terminal (PIN) domain, which is a
compact ribonuclease domain consisting of an αβ-
fold harboring four highly conserved acidic residues
required for catalysis.13 PIN domains have only
been functionally characterized in a few cases but
are believed to cleave single-stranded RNA in a
sequence and divalent metal-ion-dependent
manner.14 They are found in all domains of life
but are in bacteria mainly encoded by vapBC loci,
where they are active on a range of substrates
including mRNA and tRNA14 and often in a
sequence-specific manner like their eukaryotic
counterparts.6 Interestingly, vapBC loci are common
among pathogenic bacteria, such as Mycobacterium
tuberculosis, which contains an astounding 47 vapBC
loci.1 The evolutionary benefit of having such an
extreme number of similar genetic loci is not known,
but recent results suggest that the loci are involved
in the formation of persister cells, which are critical
to pathogeniticy.15 Crystal structures of VapBC
complexes and isolated VapC toxins currently exist
from both archaea and the pathogenic bacteria M.
tuberculosis and Neisseria gonorrhoeae.16–18 Like other
TA systems, VapBC regulate their own transcription
through binding of VapBC complexes to operators
in its own promoter region.19–21 The structure of the
N. gonorrhoeae FitAB complex, which is a VapBC-
type TA system, bound to its operator site on DNA
showed that the complex forms relatively loose
hetero-octamer structure that interacts with DNA
through two ribbon–helix–helix motifs.18 However,
in the structure of unbound VapBC-5 from M.
tuberculosis, the DNA-binding region of VapB was
disordered and could not be resolved (Table 2).17
Recently, it was found that VapC (MvpT) from the
Gram-negative pathogen Shigella flexneri 2a viru-
lence plasmid pMYSH6000 functions by specifically
cleaving initiator tRNAfMet in the anticodon region,
thus globally down-regulating translation.22 This
showed that VapC toxins are capable of very
specifically recognizing molecular targets and open
up entirely newways of fine-tuning cell metabolism.
In order to understand the activity, mode of
inhibition, and DNA-binding properties of the
VapBC family, we have determined the crystal
structure of the VapBC complex from S. flexneri.
The structure reveals a compact hetero-octameric
assembly with two unique DNA-binding domains
of the SpoVT/AbrB type that have not been
previously observed in VapBC complexes. Gel
permeation chromatography and in vitro cross-
linking experiments confirm that the octamer is
present in solution and in the crystal, thus stronglysuggesting that S. flexneri VapBC interacts with the
promoter through interaction with adjacent major
grooves.Results and Discussion
Overall structure of the S. flexneri VapBC
complex
His6-VapB:VapC was expressed in Escherichia coli
from a bicistronic construct encoding genes opti-
mized for expression, purified by Ni-NTA and gel-
filtration chromatography, and concentrated to
7 mg/ml before crystallization. Large hexagonal
crystals containing both components appeared in
1.0 M ammonium sulfate and 0.5% (v/v) polyeth-
ylene glycol 3350 at pH 5.5 and diffracted to about
2.7 Å. Following unsuccessful attempts at structure
determination by molecular replacement using
existing VapBC structures, the structure was even-
tually determined by single isomorphous replace-
ment with anomalous scattering (SIRAS) using a
uranyl acetate data set to 2.9 Å and refined to a final
R (Rfree) of 18.2% (23.7%) using iterative rebuilding
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Fig. 1. Structure overview. (a) The VapBC hetero-dimer shown in ribbon representation labeled with termini and
secondary structure elements. The VapC toxin is in blue, and the VapB antitoxin is in orange. (b) Overview on the hetero-
octameric assembly of four VapBC hetero-dimers found in the asymmetric unit, shown in top and side views with VapC
in shades of blue and with VapB in shades of orange/yellow. The two DNA-binding domains formed upon dimerization
of adjacent VapBmolecules are orange and yellow, and on the top view, the dyad axis is indicated in a black lens shape. (c)
Interaction of conserved hydrophobic residues in VapB (yellow) with the hydrophobic core of VapC. VapC is shown as a
semitransparent surface colored from white (hydrophobic) to blue (hydrophilic) with the cartoon inside. This figure and
subsequent structure figures were produced with PyMOL (Schrödinger, LLC).
715Structure of the S. flexneri VapBC Complexand refinement in Coot and PHENIX (see Table 1 for
crystallographic data statistics). The asymmetric
unit contains four copies of both VapB and VapC,
for which the VapC structures are complete (resi-
dues 1–132), while the VapB structures cover
residues 2–67 of the complete sequence (1–75). The
C-terminal residues 68–75 of VapB extend into the
solvent region and are not visible.
S. flexneri VapC contains a typical PIN domain
structure consisting of a small and central five-
stranded β-sheet (β1–β5) surrounded by seven
α-helices, denoted α1 through α7 (Fig. 1a, blue).
VapB has an N-terminal domain consisting of four
β-strands (residues 1–45), which dimerizes with aneighboring VapB to form a complete DNA-binding
domain, and an extended C-terminal tail (residues
46–67) that wraps around VapC (Fig. 1a, orange). In
the crystal, the four copies of VapBC in the
asymmetric unit form a large and globular
VapB4C4 hetero-octameric assembly, consisting of
two VapB2C2 complexes related to each other by a
dyad axis (Fig. 1b, top view; the dyad is indicated by
the black lens shape at the center). The VapB2C2
complexes are strongly stabilized through interac-
tion of the VapB N-terminal domains to form two
DNA-binding domains (Fig. 1b, side view). The
VapB2 dimer itself has an interface area of 1510 Å
2
(Fig. 1b, orange/yellow chains) and consists of a
Table 2. Comparison of S. flexneri VapBC with similar structures
Structural similarity (RMSD Cα positions) (Å)
VapC (core only) M. jannaschii FEN-1 nuclease (PDB 1A7623) 3.44
VapC N. gonorrhoeae FitB (PDB 2H1O18) 1.78
VapC M. tuberculosis Rv0301 (VapC) (PDB 3H87) 2.15
VapC M. tuberculosis VapC-5 (PDB 3DBO17) 0.97
VapB (N-domain) B. subtilis AbrB (N domain, PDB 2K1N26) 3.66
VapB (β3+4 only) B. subtilis AbrB (β3+4 only, PDB 2K1N26) 0.76
Root-mean-square deviation values (RMSD; measured in angstroms) are calculated by superpositioning of the indicated VapBC
components (left column) onto other known structures (middle column). RMSD values are for Cα atoms only.
Arg 64
Glu 42
Asp 7
Asp 98
Glu 119
Gln 66
FEN-1
Asp 80Asp 224
Glu 154
Mn2+
Asp 27
Mn2+
1
2
Asp 175
VapBC(a)
(b)
Fig. 2. Comparison of the active site of VapC to FEN-1
nuclease. (a) Close-up of the active site of VapC shown in
blue with yellow sticks andwith relevant residues of VapB
in orange sticks. Residues shown with yellow sticks are
conserved in PIN domains. Water molecules in the active
site are shownwith red small spheres. (b) The active site of
the M. jannaschii flap endonuclease (FEN-1; PDB 1A7618)
shown in the same orientation as in (a). Conserved active-
site residues are shown as yellow sticks; non-conserved
residues, in green; and the two Mn2+ ions, as violet big
spheres.
716 Structure of the S. flexneri VapBC Complexlayer of a four-stranded and a three-stranded
antiparallel β-sheets. Interactions between the two
VapC molecules in the VapB2C2 assembly are weak
and water mediated (Fig. 1b, e.g., VapC2/VapC1,
the dark-blue chains); however, there are strong
interactions to the two VapC molecules of the
adjacent VapB2C2 hetero-tetramer mediated
through helices α4, α5, and α6 with a total interface
area of 1050 Å2 (Fig. 1b, e.g., VapC2/VapC3, the
dark-blue and white chains). Overall, these interac-
tions give rise to a ring-shaped structure with
weaker water-mediated contacts at the center.
Interestingly, the DNA-bound conformation of the
N. gonorrhoeae FitAB hetero-octamer shows a ring-
shaped structure similar to but much more loose
and open than that observed for VapBC (Table 2 and
Supplementary Fig. 1).
The VapB C-terminal domain inhibits VapC by a
conserved mechanism
The interaction between the extended C-terminal
region of VapB and the VapC PIN domain shows
two main features, which are replicated in all four
copies in the asymmetric unit. Firstly, four aromatic
residues in VapB (Trp47, Trp50, Phe51, and Phe60)
point into the hydrophobic interface between helices
α1, α2, α3, and α4 of VapC where they interact
tightly with the hydrophobic core of the protein (Fig.
1c). Secondly, near the C-terminus of VapB, the side
chains of Arg64 and Gln66 of VapB point directly
into the active site of VapC, where they make close,
charged interactions to the conserved acidic active
residues Asp7, Glu42, and Asp98 (Fig. 2a). In this
interaction, the guadinium group of Arg64 interacts
strongly with the carboxylic oxygen atoms of Glu42
and Asp98 in VapC through two hydrogen bonds to
each residue. VapB Arg64 makes additional contacts
to a water molecule located in the active site, which
is also coordinated by Asp7, Asp98, and the main-
chain nitrogen of Thr8 in VapC (the latter is not
shown). In the FitAB complex, Arg68 in Fit B
engages in a similar close interaction with the
active-site residues of FitA, confirming the general-
ity of this observation.18 In addition, a BLAST
search using only the C-terminus of VapB (residues
46–75) identified 110 VapB proteins with a sequencesimilarity of 54–95%, and a multiple sequence
alignment reveals a high degree of conservation
for both interaction regions (i.e., the intercalating
aromatic residues, as well as Arg64 and Gln66;
Supplementary Fig. 2, marked in red). The high level
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Fig. 3. S. flexneri VapBC forms a hetero-octamer in
solution. (a) Chromatogram from gel permeation chroma-
tography using a 24-ml Superdex 200 10/300 GL column
showing a major early peak containing both VapB and
VapC at an elution volume of 12.7 ml, corresponding to a
molecular mass of 105 kDa. Vo is the void volume
(approximately 8 ml). OD280 is shown in blue, and
OD260 is shown in red. (b) DMSI cross-linking time-course
717Structure of the S. flexneri VapBC Complexof conservation strongly suggests that these are
general mechanisms of inhibition within the VapBC
group. Interestingly, however, in the structure of the
M. tuberculosis VapBC-5 complex, the arginine was
found in a different orientation, which may indicate
that not all interactions are simultaneously required
for inhibition to take place.17
In order to understand the functional implications
of the close interactions at the active site, we
superimposed the structure of VapB-inhibited
VapC on the PIN domain from Methanococcus
jannaschii flap endonuclease-1 [FEN-1; Protein Data
Bank (PDB) ID: 1A76], which is more well charac-
terized functionally.23 Overall, the superposition
gives a good fit of secondary structure elements
surrounding the active site and places all four
conserved acidic residues in reasonable positions
(Table 2 and Fig. 2b). Although the cleavage
mechanism employed by PIN domains is still
debated,14 there is growing evidence that it involves
two divalentmetal ions at the active site, coordinated
by the acidic residues.13,14 Mutant studies implicate
metal ion 1 (Fig. 2b, right) directly in the cleavage
mechanism, whereas metal ion 2 (left) is thought to
stabilize the conformation of the active site and
enhance substrate binding.23 Both ions are present in
the FEN-1 structure, and comparison to VapC
reveals that the positively charged guadinium
group of Arg64 in VapB appears to take up the
position of metal ion 1 (Fig. 2b), while Gln66 may
substitute metal ion 2. Together, this suggests that
the nuclease activity of VapC is at least in part
inhibited through displacement of the natural
divalent metal ions from the active site.experiment analyzed by 15% Coomassie-stained SDS-
PAGE with tentative assignment of the cross-linked
species. MW is a molecular mass standard with the
indicated sizes in kilodaltons. Monomeric VapC weighs
15 kDa, and VapB, 10 kDa.S. flexneri VapBC forms a higher-order structure
in solution
As the higher-order octameric structure observed
in the crystal structure of S. flexneri VapBC could
arise due to crystal packing interactions, we asked if
this VapBC complex also forms a higher-order
structure in solution. Analysis of purified VapBC
by high-resolution gel permeation chromatography
using a 24-ml Superdex 200 10/300 GL column
showed a major early peak containing both VapB
and VapC around 12.7 ml. Consistently, this elution
volume corresponds to a molecular mass of approx-
imately 105 kDa (Fig. 3a), closely fitting the
predicted size of a hetero-octameric VapB4C4 com-
plex (VapC=15 kDa, VapB=10 kDa, and VapB4-
C4=100 kDa). We also analyzed the purified VapBC
complex by chemical cross-linking using dimethyl
superimidate (DMSI), which shows an increasingly
complex pattern of higher-order complexes appear-
ing over time (Fig. 3b). Early cross-linked complexes
indicate formation of VapB2 (20 kDa) and VapBC
(25 kDa) dimers (10 min), while later on, presumablydue to variations in accessibility of cross-linking
sites, VapB4, VapB2C2, and VapC4 species appear.
The observation of a molecular species heavier than
50 kDa strongly indicates that a tetramer of VapC
molecules is present in solution (molecular mass,
15 kDa) and, consequently, that the hetero-octamer
is the prevalent oligomeric assembly due to the
strong interaction between VapB and VapC. The
lower abundance of the higher-order complexes on
the gel is likely due to the statistical chance of cross-
linking all four molecules in the same complex
combined with accessibility of cross-linking sites.
Thus, based on combination of gel permeation
chromatography and chemical cross-linking, we
therefore conclude that VapB and VapC assemble
as an octameric complex in solution, consistent with
the crystal structure.
(a)
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Fig. 4. VapBC contains a SpoVT/AbrB-type DNA-binding domain. (a) Left: The DNA-binding domain in VapB
resulting from homodimerization of two N-terminal domains (shown in red and green). Right: The homologous DNA-
binding domain found in B. subtilis AbrB (light red/light green; PDB 2K1N26). The annotation of secondary structure
elements for VapB follows the standard used for AbrB. (b) A model for the interaction between the VapB DNA-binding
domain and linear B-form DNA with putative interacting residues in green. Both Lys18 residues from the VapB dimer
interact with the DNA backbone, while residues 8–11 are proposed to interact with the DNA major groove. (c) An
overview model of how DNA binding to adjacent major grooves might be accomplished by the VapBC hetero-octamer.
Color scheme as in Fig. 1b. ma, major groove; mi, minor groove.
718 Structure of the S. flexneri VapBC ComplexVapB dimerizes to form a SpoVT/AbrB-like
DNA-binding domain
A BLAST search using the N-terminal sequence of
S. flexneri VapB (residues 1–45) identifies the region
as a putative SpoVT/AbrB-like DNA-binding do-
main (Pfam accession number PF04014). AbrB is a
transcriptional regulator found in Bacillus subtilis,
which is involved in the regulation of more than 60
genes.24 The solution structure of the DNA-binding
domain of AbrB revealed the so-called “swapped
β-hairpin” fold, in which two molecules each contai-
ning two β-hairpins dimerize through interweavingof the hairpins, forming a layered β-sandwich (Fig.
4a, right).24 Analogously, in the octamer structure of
VapBC, the four N-terminal VapB domains come
together to form two DNA-binding domains each
consisting of a three-stranded antiparallel β-sheet
(β1′+β2′ and β2″; Fig. 4a, left, top layer) and a four-
stranded antiparallel β-sheet (β3′+β4″ and β3″+
β4″; left, bottom layer). The two β-sheets pack
tightly against each other in a layered fashion to
form the complete DNA-binding domain. Because
the three-stranded β-sheets are formed asymmetri-
cally (i.e., with one strand from one molecule and
two from the other), two of four VapB molecules
VapBC- + - + - + - +
Control DNA I DNA II DNA III
1 2 3 4 5 6 7 8
-10-35
DNA I
DNA III DNA II
(a)
(b)
Fig. 5. VapBC specifically binds the promoter DNA at two operator sites. (a) The sequence of the S. flexneri vapBC
promoter region with the −10 Pribnow box and the −35 sequences is indicated in boldface. The transcription start site is
shown with a bent arrow, and putative VapB binding sites in adjacent major grooves are indicated by broken lines. The
position and extent of the DNA oligos (DNA I, DNA II, and DNA III) analyzed in (b) are indicated with continuous lines.
(b) EMSA showing 32P-labeled DNA fragments binding to VapBC. Control DNA (lanes 1 and 2), DNA I (lanes 3 and 4),
DNA II (lanes 5 and 6), or DNA III (lanes 7 and 8) were incubated with (+) or without (−) 2.5 ng/μl VapBC, and DNA and
protein–DNA complexes were separated by 6% native PAGE. Arrows indicate shifted protein–DNA complexes.
719Structure of the S. flexneri VapBC Complexhave an N-terminal domain consisting of two long
and two short β-strands, while the other VapB
molecules in our structure contain two long and a
single short β-strand. The N-termini that only
contribute a single short β-strand are extended and
engage in crystal contacts with other symmetry-
related octamers in the crystal. We speculate that the
complete β-sandwich is formed upon binding to
DNA. Interestingly, the DNA-binding domain is
reminiscent of the β-barrel found in the MazEF TA
complex but without the continuous interstrand
hydrogen bonds required to form a proper
β-barrel.25 This is therefore, to our knowledge, the
first observation of a layered DNA-binding domain
in bacterial TA systems.
In the DNA-binding domain of AbrB, the layers
of β-sheets are connected by short two-turn
α-helices. In comparison to VapB, we find that
these are much shorter (Table 2 and Fig. 4a). In
addition, in AbrB, the loops connecting β1′ and β2′
corresponding to residues 8–11 in VapB have beenshown to be involved directly in sequence readout
in the major groove of DNA, while the loops
connecting β2 and β3 were predicted to be involved
in DNA backbone recognition.26 Due to the
aforementioned asymmetry in the present VapB
structure, we only observe one of the major groove-
binding loops at each end of the octamer, again
suggesting that this region may undergo induced fit
upon binding DNA. However, using the structure
of the N-terminal domain of AbrB bound to its
operator (PDB entry 2K1N), we can get some idea of
how VapB binds DNA.26 In this model, the two
Lys18 of both VapB molecules in the DNA-binding
dimer are located close to the DNA backbone and
probably contribute general affinity through
charge–charge interactions (Fig. 4b). Inside the
major groove, Ser8, Asn9, Arg10, and Ser11 from
the β-loop come very close to the DNA bases and
are therefore likely involved in sequence readout.
We predict that an analogous interaction mediated
by the other VapB molecule takes place in the same
720 Structure of the S. flexneri VapBC Complexmajor groove on the other side of the double helix.
The residues involved in direct contacts are only
partially conserved across species, but similar
functional groups are found close by in the related
sequences, suggesting that the loops are used to
adapt the domain to varying DNA sequences
(Supplementary Fig. 3). Considering the entire
octamer structure and the orientation of the two
DNA-binding domains relative to each other, we
find that the distance does not match exactly an
integer multiple of helical turns and further that the
domains are rotated 56° with respect to one another.
This supports the idea that induced fit takes place
upon DNA binding, either through deformation
(bending) of the DNA or through conformational
changes in the protein (Fig. 4c). Furthermore, the
relative orientation of the two domains suggests
that the DNA is approached from two sides and
thus clamped by the VapBC complex.
VapBC binds to two operator sites
To functionally investigate the binding of VapBC
to promoter DNA, we first inspected the vapBC
promoter region on the S. flexneri pMYSH6000
genome, which revealed two putative VapBC
binding sites overlapping with the −10 Pribnow
box and the −35 sequence (Fig. 5a, shown with
broken lines). The specificity of VapBC toward these
putative operator sites was then investigated by
electrophoretic mobility shift assays (EMSA) using
three different DNA fragments spanning either one
or both of the regions. Incubation of the VapBC
complex with the entire vapBC promoter region
(DNA I) results in formation of two distinct
complexes (Fig. 5b, lanes 3 and 4, and Supplemen-
tary Fig. 4a, lanes 7–12). VapBC is specific to these
promoter sequences as no shifts are observed when
the complex is incubated with an unrelated control
DNA amplified from the pUC plasmid (Fig. 5b,
lanes 1 and 2, and Supplementary Fig. 4a, lanes 1–6).
This indicates that VapBC specifically binds to two
sites in the vapBC promoter region. To further
delineate the observed mode of binding, we
incubated VapBC with two smaller DNA fragments
containing the isolated operator sites (DNA II and
DNA III; Fig. 5a and b). In each case, incubation
produces single shifts (Fig. 5b, lanes 5–8). Since the
VapB4C4 octamer is the stable form in solution, this
strongly suggests that two VapBC octamers bind in
the promoter region. Both DNA II and DNA III have
identical lengths, and the shifts observed are of
equal size, which indicates that the complexes
formed with DNA II and DNA III are identical.
However, the band shift observed for DNA III is of
higher intensity than that for DNA II, which further
suggests that VapBC has the highest affinity for the
operator site overlapping with −35 sequences
(compare Fig. 5b, lanes 6 and 8, and SupplementaryFig. 4b, lanes 1–6 and 7–12). Both operator sites
overlap with RNA polymerase binding sites; thus,
VapBC binding to either site most likely results in
transcriptional repression.
Conclusion
In this paper, we have shown that the S. flexneri
VapBC complex forms a large hetero-octameric
assembly both in solution and in the crystal
structure. This assembly most likely represents the
biologically significant unit of the complex in vivo,
and we predict that two copies of the assembly bind
the promoter and thus regulate transcription from
the VapBC operon, either through deformation of
the DNA or protein induced fit. Previous crystal
structures of isolated VapBC complexes from N.
gonorrhoeae, M. tuberculosis, and archaeal homo-
logues showed hetero-tetrameric multimers, while
the DNA-bound structure of N. gonorrhoeae FitAB
revealed a hetero-octameric assembly similar to that
of S. flexneri VapBC, which seems to be required for
DNA binding.16–18 However, FitAB contains a
helical DNA-binding domain, and the structure is
much more open than VapBC, which is the first
example of a TA system containing an AbrB/
SpoVT-type DNA-binding domain. The DNA-bind-
ing motif in VapBC forms through homodimeriza-
tion of the antitoxin, and it may therefore be one of
the main determinants for whether TA complexes
form tetramers or octamers. Future studies will
hopefully reveal the structural basis for promoter
recognition by S. flexneri VapBC and the mode of
interaction with the toxin target tRNAfMet.Materials and Methods
Protein expression and purification
The construct pKW812HB22 was used for expression of
His6-VapB:VapC in E. coli C41 (DE3). Cells grew in 1× LB
containing 100 μg/ml ampicillin and were induced with
1 mM IPTG at an OD600 of 0.5. Expression was carried out
overnight at 25 °C with vigorous shaking (120 rpm) before
harvesting cells (15 min, 12,000g) and resuspension in
50 mM Tris (pH 8.0), 500 mM NaCl, 5 mM MgCl2, 5 mM
β-mercaptoethanol, 10 mM imidazole, and protease
inhibitor tablets (Sigma). For cell disruption, high-pres-
sure homogenization at 15,000 psi and sonication were
combined, and the resulting cell lysate was cleared by
centrifugation at 15,000 rpm for 45 min and was loaded
onto a pre-packed 5-ml HiTrap Ni-NTA column (GE
Healthcare) followed by extensive column washing (20
column volumes) in 50 mM Tris (pH 8.0), 500 mM NaCl,
5 mM MgCl2, 5 mM β-mercaptoethanol, and 35 mM
imidazole. Finally, the nearly pure VapBC complex was
eluted with 50 mM Tris (pH 8.0), 500 mM NaCl, 5 mM
MgCl2, 5 mM β-mercaptoethanol, and 300 mM imidazole.
For crystallization and cross-linking, the sample was
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with a 5-kDa molecular mass cutoff and was further
purified by gel filtration in 25 mM Tris (pH 8.0), 500 mM
NaCl, 5 mM MgCl2, and 5 mM β-mercaptoethanol on a
Superdex 200 10/300 HR column (GE Healthcare). VapBC
used for EMSA was purified from E. coli C41 (DE3)
containing the plasmid pKW812HC,22 which has the His-
tag on VapC to prevent interference with the DNA-
binding domain (VapB:His6-VapC). The protein was
purified once by Ni-NTA using phosphate buffers
[50 mM NaH2PO4 (pH 8.0), 0.3 M NaCl, 10/25/500 mM
imidazole, and 5 mM β-mercaptoethanol] and subse-
quently dialyzed overnight against storage buffer (1×
phosphate-buffered saline, 20% glycerol, and 1 mM DTT)
at 4 °C.Chemical cross-linking
Prior to the experiment, the Tris buffer was exchanged
for 100 mM sodium borate, pH 9.1, using a Vivaspin 6 spin
filter with a 5-kDa molecular mass cutoff (GE Healthcare)
to prevent reaction of the cross-linking agent with the free
amines of the buffer molecules, and the protein was
concentrated to 1 mg/ml. A reaction containing 50 μl of
1 mg/ml VapBC complex and 5 μl of 20 mg/ml DMSI was
prepared, and11 μl aliquots was removed after 5, 10, 30,
60, and 120 min. The reaction was stopped with 4 μl of 2 M
Tris, pH 8.0, and samples were analyzed by 15%
Coomassie-stained SDS-PAGE.Crystallization and structure determination
For crystallization, the protein sample from gel
filtration was concentrated to 7 mg/ml in gel-filtration
buffer. Large single VapBC crystals appeared after
3–4 days in 0.1 M Bis-Tris (2-[bis(2-hydroxyethyl)
amino]-2-(hydroxymethyl)propane-1,3-diol) (pH 5.5),
1 M ammonium sulfate, and 0.5% (v/v) polyethylene
glycol 3350 at 19 °C using sitting-drop vapor diffusion in
a 1:1 ratio of protein to crystallization buffer. Before data
collection, crystals were cryo-protected by serial transfer
into drops containing 10–20% glycerol and flash frozen in
liquid nitrogen. Uranium derivative crystals were pre-
pared by soaking the crystals for 3 h in mother liquor
supplemented with 1.25 mM UO2(CH3OCOO
−)2 (uranyl
acetate). Data collection for native crystals was carried
out at beamline ID23-1 at European Synchrotron Radia-
tion Facility, Grenoble, with detectable diffraction to
about 2.7 Å. The native data set has an unusually high
redundancy (22-fold), giving rise to relatively high
symmetry R-factors; however, the data are of very high
quality, which are also witnessed by the redundancy-
corrected R-factor Rmrdg,F (see Table 1). Uranium deriv-
ative crystals diffracted to 2.9 Å and data were collected
at beamline i911-2 at MAX-Lab in Lund, Sweden.
Indexing, integration, and scaling were carried out
using XDS for both native and derivative data,27 and
PHENIX was used to solve and refine the structure.28
Briefly, the uranium derivative data were used to solve
the phase problem for VapBC by SIRAS. The initially
obtained experimentally phased electron density map
was submitted for automatic model building using
phenix.autobuild, and the model was then iterativelyupdated manually and refined using Coot29,30 and
phenix.refine, respectively.
Electrophoretic mobility shift assay
The control DNA fragment and DNA I containing both
vapBC operator sites were amplified in a PCR reaction
using primers 171SR14 (5′-GGGGCAGCTGGC-
GAAAGGGGGATGTGCTGC) and 171SR16 (5-
GGGGCAGCTGAATTTCACACAGGAAACAGCTA)
and SF-EMSA-f (5′-GGCCGGCCCAGCGTTCTC) and SF-
EMSA-r (5′-TGCTGAGAAATACGGTGG), respectively.
Prior to the PCR amplification, primers 171SR14 and SF-
EMSA-f were 5′ end-labeled with [γ-32P]ATP using T4
polynucleotide kinase (New England Biolabs). 171SR14
and 171SR16 produce a 199-bp DNA fragment of pUC
plasmid DNA, while SF-EMSA-f and SF-EMSA-r produce
a 212-bp DNA fragment containing the entire vapBC
promoter region. The DNA II and DNA III fragments were
created by hybridizing SF-EMSA1-f (5′-ACAATAGATA-
TACACAAGACATATCCACAT) and SF-EMSA1-r
(5′-ATGTGGATATGTCTTGTGTATATCTATTGT) and
SF-EMSA2-f (5′-ATAAACGTATATCCCTTTGACA-
TATCCCGG) and SF-EMSA2-r (5′-CCGGGATATGT-
CAAAGGGATATACGTTTAT), respectively. Prior to
hybridization, primers SF-EMSA1-f and SF-EMSA2-f
were 5′ end-labeled as described above. Labeled DNA
fragments (1 nM) were incubated with purified protein
complex in binding buffer [20 mM Tris–HCl (pH 7.5),
100 mM KCl, 2 mM MgCl2, 1 mM DTT, 50 μg/ml bovine
serum albumin, and 10% glycerol]. To avoid nonspecific
DNA binding, we added sonicated salmon sperm DNA to
a final concentration of 0.1 mg/ml. Reactions were
incubated for 20 min at 37 °C, protein–DNA complexes
were separated by native PAGE in 6% acrylamide gels
with 0.5× Tris–borate–ethylenediaminetetraacetic acid,
and the separated complexes were visualized by phosphor
imaging.
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